Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates

Marnix Lameijer, Tina Binderup, Mandy M.T. Van Leent, Max L. Senders, Francois Fay, Joost Malkus, Brenda L. Sanchez-Gaytan, Abraham J.P. Teunissen, Nicolas Karakatsanis, Philip Robson, Xianxiao Zhou, Yuxiang Ye, Gregory Wojtkiewicz, Jun Tang, Tom T.P. Seijkens, Jeffrey Kroon, Erik S.G. Stroes, Andreas Kjaer, Jordi Ochando, Thomas ReinerCarlos Pérez-Medina, Claudia Calcagno, Edward A. Fischer, Bin Zhang, Ryan E. Temel, Filip K. Swirski, Matthias Nahrendorf, Zahi A. Fayad, Esther Lutgens, Willem J.M. Mulder, Raphaël DuivenvoordenMostrar 11 otrosMostrar menos